Home » Healthcare » Glucose Monitoring System Market

Glucose Monitoring System Market By Product (Continuous Monitoring Devices [Monitors, Sensors, Transmitters], Self-monitoring Devices); By Indication (Diabetes Type I, Diabetes Type II, Gestational Diabetes); By End-user (Hospitals, Clinics, Home Care Settings); By Geography – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4999

Published: | Report ID: 36691 | Report Format : PDF
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Glucose Monitoring System Market Size 2024  USD 27,756.21 Million
Glucose Monitoring System Market, CAGR  10.10%
Glucose Monitoring System Market Size 2032  USD 59,932 Million

Market Overview

The Glucose Monitoring System Market is projected to witness significant growth, soaring from USD 27,756.21 million in 2024 to USD 59,932 million by 2032, with a robust compound annual growth rate of 10.10%.

The Glucose Monitoring System Market is being propelled by several key drivers and trends. Increasing prevalence of diabetes, particularly type 2, is fostering heightened demand for efficient glucose monitoring solutions. Technological advancements, such as the integration of continuous glucose monitoring (CGM) systems and wearable devices, are enhancing patient convenience and data accuracy. Moreover, rising awareness regarding proactive management of diabetes and the emphasis on preventive healthcare measures are further fueling market growth. Additionally, initiatives aimed at improving access to healthcare services, coupled with favorable reimbursement policies for diabetes management devices, are contributing to the expansion of the glucose monitoring system market.

Geographical analysis reveals a diversified landscape in the Glucose Monitoring System Market, with North America leading due to robust healthcare infrastructure and high prevalence of diabetes. Europe follows suit, driven by technological advancements and favorable reimbursement policies. The Asia-Pacific region exhibits immense growth potential, attributed to the increasing adoption of glucose monitoring devices and rising healthcare expenditure. Key players dominating the market include Abbott Laboratories, Dexcom Inc., Medtronic plc, F. Hoffmann-La Roche Ltd, and Becton, Dickinson and Company. These industry giants are focusing on strategic collaborations, product innovations, and geographical expansions to maintain their competitive edge in the global market.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Drivers

Rising Prevalence of Diabetes

Diabetes, particularly type 2 diabetes, is reaching epidemic proportions globally. The International Diabetes Federation estimates that nearly half a billion people worldwide have diabetes, and this number is projected to rise significantly in the coming years. This growing diabetic population creates a massive demand for effective blood sugar monitoring systems. More than 90% of people with diabetes have type 2 diabetes, which is driven by socio-economic, demographic, environmental, and genetic factors. The key contributors to the rise in type 2 diabetes include urbanization, an aging population, decreasing levels of physical activity, and increasing prevalence of overweight and obesity. Therefore, it is crucial to take preventive measures for type 2 diabetes and provide early diagnosis and proper care for all types of diabetes. These measures can help people living with the condition avoid or delay complications.

Growing Awareness of Prediabetes

There’s also a rise in awareness of prediabetes, a condition where blood sugar levels are higher than normal but not yet high enough to be classified as diabetes. For instance, approximately 98 million American adults more than 1 in 3 have prediabetes. Of those with prediabetes, more than 80% don’t know they have it. Early detection and lifestyle modifications are crucial for pre-diabetics to prevent progression to full-blown diabetes. Glucose monitoring systems empower pre-diabetics to track their blood sugar levels and make informed dietary and lifestyle choices. For example, the CDC-led National Diabetes Prevention Program can help pre-diabetics make lifestyle changes to prevent or delay type 2 diabetes and other serious health problems.

Increasing Focus on Preventative Healthcare

A general shift towards preventative healthcare practices is driving the market. For instance, the Healthy People 2030 initiative focuses on increasing preventive care for people of all ages. However, despite the availability of preventive care, millions of people in the United States don’t get recommended preventive health care services.

People are becoming more proactive about managing their health and preventing chronic diseases. For example, about 50% of adults have at least one of 10 select chronic conditions, and seven out of 10 deaths among Americans each year are due to chronic diseases, many of which are preventable.

Glucose monitoring systems allow individuals, especially those at risk of diabetes due to family history or lifestyle factors, to monitor their blood sugar and identify potential problems early on. This is particularly important given that in adults, type 2 diabetes accounts for approximately 90-95% of all diagnosed cases of diabetes. Risk factors for Type 2 diabetes include being overweight, having a family history, being physically inactive, and being 45 and older. Over 90% of people with diabetes have type 2 diabetes, which is driven by socio-economic, demographic, environmental, and genetic factors.

Advancements in Technology

The constant innovation in glucose monitoring technology is another key driver. We’re seeing the development of minimally invasive and painless testing methods such as continuous glucose monitoring systems (CGMS) that use sensors inserted under the skin to provide real-time blood sugar data. This eliminates the need for finger pricking, which can be a deterrent for some users. Additionally, smart and connected devices are becoming more integrated with smartphones and telehealth platforms, allowing for data sharing with healthcare providers, remote monitoring, and personalized feedback, leading to improved diabetes management.

Market Trends

Focus on Non-Invasive and Painless Monitoring

These minimally invasive devices with sensors inserted under the skin offer real-time glucose readings, eliminating the need for frequent finger pricks. For instance, most current CGMs (Medtronic-Guardian, Dexcom-G6, and Abbott-Libre-2) have MARD (Mean Absolute Relative Difference) values of less than 10%, indicating high accuracy. These devices also last for 10–14 days, significantly reducing the frequency of sensor changes.

Advancements in sensor technology are making CGMS more comfortable to wear and longer-lasting. For example, the Eversense-3, an implantable CGM, lasts for 6 months and is now approved in the USA and Europe. Research is ongoing for technologies that measure blood sugar levels through sweat, tears, or breath analysis. These non-invasive options could improve user comfort and adherence to monitoring routines. For instance, optical methods for CGM, including near-infrared (NIR) spectroscopy, mid-infrared (MIR) spectroscopy, Raman spectroscopy, photoacoustic (PA) spectroscopy, fluorescence technology, optical coherence tomography (OCT), holographic technology, and hydrogel sensing technology are being explored.

Integration with Mobile Apps and Telehealth

Users can visualize trends, identify patterns, and gain insights into their blood sugar fluctuations. Apps can suggest dietary adjustments, medication reminders, or lifestyle changes based on the collected data. For instance, More than half of respondents with type 1 diabetes and one third of respondents with type 2 diabetes reported using diabetes apps for self-management. Popular apps include “mySugr” and continuous glucose monitoring apps, such as “Dexcom,” “Freestyle Libre,” and “Xdrip+”.

Diabetics can share their glucose data with healthcare providers for remote monitoring and receive ongoing support through telehealth platforms. The use of telehealth for diabetes care has significantly increased. For example, internet-based surveys conducted in spring of 2020 indicated that the majority of U.S. endocrinologists had moved to entirely or predominantly virtual care, and that 28% of individuals with type 1 diabetes globally had already engaged in remote diabetes care as a result of the pandemic. This shift towards telehealth has the potential to improve access to quality diabetes care.

Market Challenges Analysis

Cost and Accessibility

Current glucose monitoring systems, particularly advanced Continuous Glucose Monitoring Systems (CGMS) devices, often come with a hefty price tag. The cumulative costs of sensors, transmitters, and mobile app subscriptions can pose a significant financial burden for many patients. This disparity in accessibility highlights the urgent need for the development of more affordable options. Additionally, exploring insurance coverage possibilities is crucial to ensure equitable access to this vital technology. Collaborative efforts involving healthcare providers and policymakers are essential to implement reimbursement policies that can make glucose monitoring systems more accessible to a wider patient population.

Accuracy and Data Reliability

While technological advancements have improved the capabilities of continuous glucose monitoring systems, concerns persist regarding their accuracy, particularly during periods of rapid blood sugar changes. Ensuring data reliability and fostering user confidence in the readings are paramount for effective diabetes management. Addressing this challenge requires continuous research and development efforts aimed at enhancing sensor accuracy and calibration algorithms. Moreover, providing comprehensive education and support to users is essential to help them interpret and trust their glucose monitoring data, ultimately empowering them to make informed decisions about their health.

Market Segmentation Analysis:

By Product:

The Glucose Monitoring System Market can be segmented by product type, encompassing Continuous Monitoring Devices and Self-monitoring Devices. Continuous Monitoring Devices consist of monitors, sensors, and transmitters, offering real-time glucose data without the need for frequent manual testing. Monitors track glucose levels, sensors measure glucose in bodily fluids, and transmitters transmit data to external devices. Self-monitoring Devices, on the other hand, cater to users who prefer periodic testing at their convenience. These devices typically include glucometers and test strips for measuring blood glucose levels at home. The continuous monitoring segment is expected to witness significant growth due to the rising preference for real-time data monitoring and advancements in sensor technology.

By Indication:

Segmentation based on indication includes Diabetes Type I, Diabetes Type II, and Gestational Diabetes. Diabetes Type I, characterized by the body’s inability to produce insulin, requires continuous glucose monitoring for effective management. Diabetes Type II, often linked to lifestyle factors, may necessitate both continuous and self-monitoring devices for glucose control. Gestational Diabetes, which occurs during pregnancy, also requires vigilant glucose monitoring to manage maternal and fetal health. The Diabetes Type II segment is projected to dominate the market due to the increasing prevalence of this form of diabetes worldwide.


Based on Product:

  • Continuous Monitoring Devices
    • Monitors
    • Sensors
    • Transmitters
  • Self-monitoring Devices

Based on Indication:

  • Diabetes Type I
  • Diabetes Type II
  • Gestational Diabetes

 Based on End-user:

  • Hospitals
  • Clinics
  • Home Care Settings

 Based on the Geography:

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Regional Analysis

North America

North America currently dominates the market, capturing a substantial 40% share. This region’s prominence can be attributed to the high incidence of diabetes, the well-established healthcare system, and the widespread adoption of advanced glucose monitoring solutions. The United States remains the largest contributor to the North American market, followed by Canada, where the demand for glucose monitoring systems is fueled by the increasing awareness of diabetes management and the availability of reimbursement policies.


Europe holds the second-largest market share, accounting for approximately 25% of the global revenue. The region’s focus on improving diabetes care, coupled with the increasing adoption of self-monitoring practices and the availability of innovative glucose monitoring technologies, has driven the market’s growth. Countries such as Germany, the United Kingdom, and France are the key contributors, where the emphasis on early diagnosis and effective disease management has propelled the demand for glucose monitoring systems.

Key Player Analysis

  1. Abbott Laboratories
  2. Dexcom, Inc.
  3. F. Hoffmann-La Roche Ltd
  4. Medtronic
  5. LifeScan IP Holdings, LLC
  6. Ascensia Diabetes Care Holdings AG.
  7. ARKRAY, Inc.
  8. ACON Laboratories, Inc.
  9. NIPRO
  10. Nova Biomedical

Competitive Analysis

In the fiercely competitive Glucose Monitoring System Market, leading players such as Abbott Laboratories, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Medtronic, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG, ARKRAY, Inc., ACON Laboratories, Inc., NIPRO, and Nova Biomedical are vying for market dominance. Abbott Laboratories stands out for its FreeStyle Libre system, offering continuous glucose monitoring with no finger pricks required. Dexcom, Inc. is renowned for its Dexcom G6 CGM System, known for its accuracy and user-friendly design. F. Hoffmann-La Roche Ltd’s Accu-Chek series is favored for its reliability and extensive product range. Medtronic is a key player with its MiniMed series, offering integrated insulin pump systems with continuous glucose monitoring capabilities. Other notable contenders include LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG, ARKRAY, Inc., ACON Laboratories, Inc., NIPRO, and Nova Biomedical, each contributing innovative solutions and competitive pricing strategies to capture market share.

Recent Developments

In August 2023, ACON Laboratories, Inc., headquartered in the United States, made the On Call® MultiPro System available for point-of-care testing in healthcare settings, offering rapid and accurate results, multi-language support, and connectivity options.

In February 2024, United States-based DexCom, Inc., a prominent player in real-time continuous glucose monitoring for individuals with diabetes, introduced their latest CGM system, the Dexcom ONE+.

In March 2024, the United States Food and Drug Administration (FDA) approved the marketing of the first OTC continuous glucose monitor.

Market Concentration & Characteristics

The Glucose Monitoring System Market exhibits characteristics of moderate to high market concentration, with a handful of key players dominating a significant portion of the market share. Leading companies such as Abbott Laboratories, Dexcom, Inc., F. Hoffmann-La Roche Ltd, and Medtronic command substantial influence due to their established brand reputation, extensive product portfolios, and strong distribution networks. These market leaders often set industry standards through continuous innovation in technology, product quality, and customer service. However, despite the presence of dominant players, the market remains dynamic and competitive, with smaller companies and new entrants continually striving to carve out niche segments with innovative offerings. Factors such as regulatory requirements, technological advancements, pricing strategies, and partnerships play crucial roles in shaping the competitive landscape of the glucose monitoring system market. As a result, market participants must remain agile and adaptable to evolving market dynamics to sustain their competitive edge and capitalize on emerging opportunities.

Report Coverage

The research report offers an in-depth analysis based on Product, Indication, End-user, and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Future Outlook

  1. Continued Technological Advancements: Expect ongoing innovations in glucose monitoring technology, focusing on enhanced accuracy, user convenience, and seamless integration with other healthcare platforms.
  2. Expansion of Wearable Devices: Anticipate a surge in wearable glucose monitoring devices, offering real-time data monitoring and analysis for improved diabetes management.
  3. Rising Demand for Non-Invasive Solutions: Look for increased development and adoption of non-invasive glucose monitoring technologies, reducing the need for invasive blood sampling methods.
  4. Growth in Telehealth and Remote Monitoring: Witness the expansion of telehealth services and remote monitoring capabilities, enabling more convenient and accessible diabetes management options for patients.
  5. Increasing Focus on Data Analytics: See a greater emphasis on data analytics and artificial intelligence to interpret glucose monitoring data, providing personalized insights and recommendations for users.
  6. Regulatory Landscape Evolution: Expect regulatory agencies to adapt guidelines and standards to accommodate new glucose monitoring technologies and ensure patient safety and efficacy.
  7. Expansion of Point-of-Care Testing: Watch for the proliferation of point-of-care testing solutions for glucose monitoring, enabling rapid and convenient testing in various healthcare settings.
  8. Integration with Smart Devices: Witness the integration of glucose monitoring systems with smart devices such as smartphones, smartwatches, and fitness trackers, enhancing user experience and data accessibility.
  9. Shift towards Preventative Healthcare: Experience a growing emphasis on preventative healthcare measures, driving increased adoption of glucose monitoring systems for early detection and management of diabetes.
  10. Global Market Expansion: See the glucose monitoring system market expand globally, with emerging economies witnessing accelerated adoption of these technologies alongside improving healthcare infrastructure and rising awareness of diabetes management.

1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope
2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology
3. Executive Summary
4. Introduction
4.1. Overview
4.2. Key Industry Trends
5. Glucose Monitoring System Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast
6. Market Breakup by Product
6.1. Continuous Monitoring Devices
6.1.1. Monitors Market Trends Market Forecast Revenue Share Revenue Growth Opportunity
6.1.2. Sensors Market Trends Market Forecast Revenue Share Revenue Growth Opportunity
6.1.3. Transmitters Market Trends Market Forecast Revenue Share Revenue Growth Opportunity
6.2. Self-monitoring Devices
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity
7. Market Breakup by Indication
7.1. Diabetes Type I
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Diabetes Type II
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity
7.3. Gestational Diabetes
7.3.1. Market Trends
7.3.2. Market Forecast
7.3.3. Revenue Share
7.3.4. Revenue Growth Opportunity
8. Market Breakup by End-user
8.1. Hospitals
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Clinics
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity
8.3. Home Care Settings
8.3.1. Market Trends
8.3.2. Market Forecast
8.3.3. Revenue Share
8.3.4. Revenue Growth Opportunity
9. Market Breakup by Region
9.1. North America
9.1.1. United States Market Trends Market Forecast
9.1.2. Canada Market Trends Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast
10. SWOT Analysis
10.1. Overview
10.2. Strengths
10.3. Weaknesses
10.4. Opportunities
10.5. Threats
11. Value Chain Analysis
12. Porters Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes
13. Price Analysis
14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Abbott Laboratories Company Overview Product Portfolio Financials SWOT Analysis
14.3.2. Dexcom, Inc.
14.3.3. F. Hoffmann-La Roche Ltd
14.3.4. Medtronic
14.3.5. LifeScan IP Holdings, LLC
14.3.6. Ascensia Diabetes Care Holdings AG.
14.3.7. ARKRAY, Inc.
14.3.8. ACON Laboratories, Inc.
14.3.9. NIPRO
14.3.10. Nova Biomedical
15. Research Methodology

Frequently Asked Questions:

What is the current size of the Glucose Monitoring System Market?

As of 2024, the Glucose Monitoring System Market is valued at approximately USD 27,756.21 million. It is projected to grow significantly to reach USD 59,932 million by 2032.

What factors are driving the growth of the Glucose Monitoring System Market?

The growth of the Glucose Monitoring System Market is driven by several factors including the rising prevalence of diabetes, especially type 2 diabetes; technological advancements in glucose monitoring such as continuous glucose monitoring systems and wearable devices; increased awareness and proactive management of diabetes; favorable reimbursement policies; and initiatives to improve healthcare access.

What are the key segments within the Glucose Monitoring System Market?

The market is segmented by product into Continuous Monitoring Devices (monitors, sensors, transmitters) and Self-monitoring Devices (glucometers, test strips). It is also segmented by indication into Diabetes Type I, Diabetes Type II, and Gestational Diabetes. Additionally, it includes segments based on end-users (hospitals, clinics, home care settings) and geography (North America, Asia-Pacific, Europe, South America, Middle East and Africa).

What are some challenges faced by the Glucose Monitoring System Market?

Key challenges include the high costs associated with advanced Continuous Glucose Monitoring Systems (CGMS), which can be a financial burden for patients; disparities in accessibility; concerns about the accuracy and reliability of glucose readings, especially during rapid blood sugar changes; and the need for ongoing education to help users understand and trust their glucose monitoring data.

Who are the major players in the Glucose Monitoring System Market?

Major players include Abbott Laboratories, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Medtronic, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG, ARKRAY, Inc., ACON Laboratories, Inc., NIPRO, and Nova Biomedical. These companies are known for their continuous innovation and strategic expansions.

Small Animal Respiratory Diseases Treatment Market

Report ID: 10022

AI in Vitro Diagnostics Market

Report ID: 39163

U.S. 503b Compounding Pharmacies Market

Report ID: 15988

UAE Minimally Invasive Biopsy Techniques Market

Report ID: 38790

Saudi Arabia Minimally Invasive Biopsy Technique Market

Report ID: 38766

Lung Cancer Therapeutics Market

Report ID: 38769

Breast Cancer Market

Report ID: 38761

Positive Patient Identification (PPID) Market

Report ID: 10622

Inflation Devices Market

Report ID: 38697

Microbiology Culture Market

Report ID: 38672

Medical Processing Seals Market

Report ID: 38667

Egypt In-Vitro Fertilization (IVF) Market

Report ID: 38526

Purchase Options

Delivery Format: Excel.
Designed for the individual purchaser.
Users located at a single corporate site or regional office.
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


24/7 Research Support

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN